Career Opportunities with Summit Therapeutics Sub, Inc.
A great place to work.
Careers at Summit Therapeutics Sub, Inc.
Current job opportunities are posted here as they become available.
Ivonescimab, known as SMT112, is a novel, potential first-in-class investigational bispecific antibody combining immunotherapy via PD-1 blockade with anti-angiogenesis effects by blocking VEGF. Ivonescimab exhibits unique cooperative binding to its targets with higher affinity when both PD-1 and VEGF are present.
Summit has initiated clinical development of ivonescimab in non-small cell lung cancer (NSCLC), with three active Phase III trials:
Ivonescimab is an investigational therapy not yet approved in the US or Europe but was approved in China in May 2024. It has received Fast Track designation from the FDA for the HARMONi trials.
Overview of Role:
The Associate Director of Facilities Management will oversee operations at our U.S. and European offices, ensuring security, compliance, cost-efficiency, and an optimal employee environment. Responsibilities include vendor management, regulatory compliance, physical security, and strategic planning to support business growth. This role requires a proactive leader capable of managing daily operations and shaping long-term facilities strategies globally.
Responsibilities:
Qualifications:
The salary range for this role is $168,000-$180,000 annually, with actual compensation based on experience, skills, certifications, and location. Benefits may include bonuses, stock options, and other variables.
Summit does not accept referrals from employment agencies without prior approval. Agencies must contact our Talent Acquisition team at ...@smmttx.com for authorization.
#J-18808-Ljbffr